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Abstract: Vulvar cancer is an uncommon disease with approximately 1000 cases reported 
annually in the UK. Lymph node involvement is an important prognostic indicator. Vulvectomy 
and bilateral groin node dissection are the preferred surgical treatments for early disease and 
increase survival. However, significant morbidity with lymphocyst formation and wound 
breakdown has been reported in more than 50% of cases. We report the first case following 
use of the PlasmaJet® neutral argon coagulation system to reduce postoperative lymphocyst 
formation.
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Introduction
Vulvar malignancy is the fourth most common malignancy of the female genital tract, 
accounting for less than 5% of all gynecologic tumors worldwide. Of these, 85% are 
squamous cell in origin, and the average age at presentation is 65 years. Surgical 
excision achieves excellent local control and remains the mainstay of treatment. 
Surgical excision depends on the extent of disease and may be in the form of wide 
local excision or radical vulvectomy. Lymphadenectomy in the form of bilateral groin 
node dissection (BGND) is performed for all central tumors with depth of invasion 
greater than 1 mm, unless there is significant comorbidity contraindicating this, but is 
known to cause significant postoperative morbidity. Immediate postoperative compli-
cations include breakdown and lymphocyst formation in more than 50% of cases. In 
our experience, management of the groin wound presents a greater clinical problem 
than the central excision wound. We report the first case of use of the PlasmaJet® (PJ) 
(Plasma Surgical Limited, Oxfordshire, UK) system following groin node dissection 
to prevent lymphocyst formation and wound complications.
Case summary
A 35-year-old multiparous lady with a body mass index of 25 was referred with a 
2-month history of an itchy, vulvar lesion, which had increased from a pea-sized mass 
to 2.5 cm, causing discomfort. She smoked ten cigarettes a day with an otherwise 
unremarkable medical history. The lesion surface appeared white with no evidence of 
bleeding or discharge. Examination under anesthetic revealed a 2.5 × 2.5 cm ulcerated 
tumor with heaped edges and extending into the vagina at the posterior fourchette. 
It appeared mobile and clear of the anal sphincter. A wedge biopsy confirmed a well-
differentiated squamous cell carcinoma (SCC) to a depth of at least 1.2 mm.Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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Following review of the pathology at the gynecology 
and oncology multidisciplinary team meeting, a radical 
posterior vulvectomy with BGND was recommended. 
In consultation with the patient, discussion focused on the 
risks of possible nerve injury to branches of the femoral nerve 
leading to paresthesia, risk of lymphocyst, and subsequent 
lymphedema formation. The PJ device was discussed and 
consent obtained to explore its use in the possible reduction 
of lymphocyst formation. She underwent a radical posterior 
vulvectomy and BGND with sparing of the long saphenous 
vein (LSV) bilaterally. The technique involved a linear 
incision along the medial – four-fifths of a line between 
anterior superior iliac spine and pubic tubercle and 1 cm 
above and parallel to the groin crease. The incision was 
carried through the subcutaneous tissues to the superficial 
fascia. Fascia lata, sartorious muscle, and external oblique 
aponeurosis were easily identified. Femoral vessels and nerve 
sheath was identified. Both superficial and deep groups of 
nodes were taken out en-bloc down to the fascia overlying the 
adductor muscles, and the saphenous vein ligated at the apex 
of the femoral triangle at the point of entry into the femoral 
vein. The left groin dissection was performed first (Figure 1). 
Following this, the PJ was used on the left groin to seal the 
lymph vessels and channels at a setting of 40% by spraying 
the PJ over the entire exposed surgical field at a distance of 
10 mm from the surface to the tip of the instrument. This step 
of the procedure took 5 minutes (Figure 2). Use of the PJ was 
limited to the left side only. Surgery to the right groin was 
otherwise identical. A redivac drain size 10 was left in both 
groins, and daily output was recorded by the nursing team 
(Table 1). Both patient and nursing staff (observers for drain 
measurement) were blinded to the side of PJ use.
The final histology confirmed a well-differentiated SCC 
with a maximum diameter of 27 mm and a maximum depth 
of 4 mm. All the margins were clear and the deepest margin 
was 3 mm. There was no evidence of lymphovascular space 
invasion. The eleven lymph nodes on the right and twelve on 
the left were uninvolved.
She was discharged 9 days postoperative with drains 
in situ and regular nursing support in the community. 
She attended a clinic 12 days later and the right groin had 
developed two separate tense lymphocysts at the medial 
and lateral aspects of the wound. The left groin appeared to 
be healing well with minimum drain output and hence the 
drain was removed. The right drain continued to produce 
significant volumes of fluid and was removed only when 
she was reviewed on day 35, when the lateral lymphocyst 
appeared to have resolved and the medial lymphocyst also 
appeared to have reduced in size. At clinic review 18 months 
postoperative, the patient reported swelling of the right leg. 
Clinically, she had lymphedema grade 2 in the right lower 
limb to the level of the thigh. The left lower limb appeared to 
be normal. Following referral to a therapist, she was managed 
with manual lymphatic drainage and support hosiery.
Figure 1 Groin node dissection with preservation of the saphenous vein.
Figure 2 The PlasmaJet® handpiece spraying neutral argon plasma to seal lymphatics 
following groin dissection.
Table 1 Daily drain outputs following bilateral groin node dissection
Day postoperative Left Right
1 100 20
2 60 300
3 40 80
4 110 160
5 85 130
6 60 140
7 20 60
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Discussion
The primary treatment modality for vulvar cancer remains 
surgery. Basset in 1912, and subsequently Taussig and Way in 
the 1940s, described en-bloc dissection involving the butterfly 
technique.1 This increased 5-year survival rates to around 
90% in stage 1 patients and an overall survival of 70% but 
resulted in prolonged hospitalization and complications due 
to wound breakdown and lymphedema, leading to significant 
morbidity.1,2 In 1962, Byron described the triple incision 
technique that was later popularized by Hacker et al and Di 
Saia and Creasman.2,3 Morbidity following the triple incision 
technique surgery is much lower, though is still significant 
with wound breakdown, seroma formation, and lymphedema 
reported in more than 50% of cases. Gaarenstroom et al 
reported one or more postoperative complications in 76% of 
treated cases leading to protracted hospital stay, psychosexual 
disturbances, negative body image, and lymphedema.5 
Rouzier et al suggested modified techniques, including 
sartorius transposition, preservation of fascia lata, and 
LSV , but concluded that transposition of sartorius did not 
decrease morbidity, though better outcomes were noted with 
preservation of fascia lata and saphenous vein.7
Two subsequent Gynecologic Oncology Group studies 
have demonstrated a 33% fall in postoperative complications 
when preserving the LSV but have also highlighted that use 
of fibrin sealants did not reduce lymphedema rates and also 
increased the risk of central wound complications.4–8
Sentinel lymph node procedure (SLN) or vulvar cancer 
in the UK is being performed as part of GROINSS-V II 
(Groningen International Study on Sentinel Nodes in Vulvar 
Cancer), which is evaluating the short- and long-term 
morbidity associated with SLN biopsy and the safety of 
replacing inguinofemoral lymphadenectomy in patients 
with negative sentinel node or metastasis less than 2 mm. 
At the time of this case, our center was not recruiting to 
this study.
The PJ is a novel device that produces a jet of pure argon 
plasma by heating pressurized argon gas. Energy from the 
argon plasma transfers to tissue as light, heat, and kinetic 
energy. It is rapidly dissipated, generating very limited 
lateral thermal damage. The light produced is in the visible 
and near ultraviolet parts of the spectrum, illuminates the 
operative field, and helps to indicate the position of the jet. 
Iannelli et al reported use of the PJ device in abdominoplasty 
and found reduced drain output and fluid output.6 This case 
demonstrates reduced daily drain outputs and no lymphocyst 
formation on the groin wound treated with PJ. Lymphedema 
was only reported on the contralateral side where the PJ was 
not used.
This case suggests a possible role for the PJ system to 
reduce postoperative wound complications following BGND, 
which needs to be explored further. Following ethical approval, 
we are currently undertaking a prospective, crossover, double-
blind, randomized, control trial to assess the PJ system, with 
the primary outcome being the possibility of reduction in 
wound breakdown and lymphocyst and lymphedema forma-
tion following BGND for vulvar cancer.
Disclosure
The device and handpiece were provided free of charge for 
this case report.
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